There is a thoughtful quote at the end of this story which makes a good lead-in to the article:
...this relatively desultory reputation is the result of the public’s rejection of the proposition that pharmaceutical and biotech firms care about patients and strive to develop innovative new medicines. It’s not hard to see why. For one thing, the ubiquitous presence of tacky direct to consumer advertisements present the industry as one more concerned with sales than with having a serious discussion about medical science with a patient and their physician. But one reason, as well, surely is the spate of government investigations and settlements based upon allegations of illegal promotion.